Another experiment also proved that miR-381-3p blocks the dual regulatory role of CCNA2 (Cyclin-A2) in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression in bladder cancer [30,31]. Here, MET is linked to urinary bladder carcinoma.